Insider Transactions

DAY HI:
DAY LOW:
VOLUME:

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Insider Transactions

Date Name Title Filing Type Shares Traded Price Range Total Held
Jun 26, 2008
Chief Scientific Officer
Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 10,000 $1.41 216,216
Jun 25, 2008
Chief Scientific Officer
Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 100 $1.48 186,216
Mar 25, 2008
Chief Scientific Officer
Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 18,000 -- 184,434
Mar 25, 2008
Chief Scientific Officer
Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 $2.55 50,000
Dec 06, 2007
Chief Scientific Officer
Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 $3.15 50,000
Nov 21, 2007
Chief Scientific Officer
Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 $2.72 166,434
Aug 01, 2007
Chief Scientific Officer
Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 $3.58 161,316
Jul 20, 2007
Chief Scientific Officer
Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 -- 156,316
Jul 20, 2007
Chief Scientific Officer
Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 150,000 $6.90 150,000
Jun 08, 2007
Chief Scientific Officer
Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 -- 110,845
Jun 08, 2007
Chief Scientific Officer
Chief Scientific Officer Form 4/A Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 -- 105,845
Dec 08, 2006
Chief Scientific Officer
Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 150,000 -- 150,000
Sep 26, 2006
Chief Scientific Officer
Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 -- 100,000
Jun 14, 2006
Chief Scientific Officer
Chief Scientific Officer Form 4 Open market or private purchase of non-derivative or derivative security 2,500 $3.75 78,034
Apr 03, 2006
Chief Scientific Officer
Chief Scientific Officer Form 4 Exercise of in-the-money or at-the-money derivative security 5,750 $3.00 75,140
Apr 03, 2006
Chief Scientific Officer
Chief Scientific Officer Form 4 Exercise of in-the-money or at-the-money derivative security 5,750 -- --
Dec 06, 2005
Chief Scientific Officer
Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 -- 69,390
Dec 06, 2005
Chief Scientific Officer
Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 -- 100,000
Jun 29, 2005
Chief Scientific Officer
Chief Scientific Officer Form 4 Open market or private purchase of non-derivative or derivative security 1,000 $4.20 39,390
May 19, 2005
Chief Scientific Officer
Chief Scientific Officer Form 4 Open market or private purchase of non-derivative or derivative security 200 $4.70 36,990
May 19, 2005
Chief Scientific Officer
Chief Scientific Officer Form 4 Open market or private purchase of non-derivative or derivative security 1,400 $4.72 38,390
Jan 03, 2005
Chief Scientific Officer
Chief Scientific Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 -- 100,000
Jan 03, 2011
CSO and Head of R&D Operations
CSO and Head of R&D Operations Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 -- 40,000
Jan 03, 2011
CSO and Head of R&D Operations
CSO and Head of R&D Operations Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 -- 50,000
Jul 23, 2010
CSO and Head of R&D Operations
CSO and Head of R&D Operations Form 5 Open market or private purchase of non-derivative or derivative security 1,125 $3.91 22,818

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.